BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 32369523)

  • 1. Regional citrate anticoagulation versus no-anticoagulation for continuous venovenous hemofiltration in patients with liver failure and increased bleeding risk: A retrospective case-control study.
    Yu Y; Bai M; Ma F; Zhang W; Li Y; Zhao L; Li L; Zhou M; Li L; Sun S
    PLoS One; 2020; 15(5):e0232516. PubMed ID: 32369523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional citrate anticoagulation versus low molecular weight heparin anticoagulation for continuous venovenous hemofiltration in patients with severe hypercalcemia: a retrospective cohort study.
    Yu Y; Bai M; Wei Z; Zhao L; Li Y; Ma F; Sun S
    Ren Fail; 2020 Nov; 42(1):748-758. PubMed ID: 32718221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional Citrate Anticoagulation versus No-Anticoagulation for Continuous Venovenous Hemofiltration in Acute Severe Hypernatremia Patients with Increased Bleeding Risk: A Retrospective Cohort Study.
    Zhao L; Ma F; Yu Y; Li Y; Wang Y; He L; Zhou M; Tian X; Jing R; Li L; Li L; Huang C; Bai M; Sun S
    Blood Purif; 2020; 49(1-2):44-54. PubMed ID: 31522180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis.
    Zhang W; Bai M; Yu Y; Li L; Zhao L; Sun S; Chen X
    Crit Care; 2019 Jan; 23(1):22. PubMed ID: 30678706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mode of CVVH with regional citrate anticoagulation compared to no anticoagulation for acute kidney injury patients at high risk of bleeding.
    Gao J; Wang F; Wang Y; Jin D; Tang L; Pan K
    Sci Rep; 2019 Apr; 9(1):6607. PubMed ID: 31036927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Customized Citrate Anticoagulation versus No Anticoagulant in Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: A Prospective Randomized Controlled Trial.
    Ratanarat R; Phairatwet P; Khansompop S; Naorungroj T
    Blood Purif; 2023; 52(5):455-463. PubMed ID: 36858026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution.
    Morabito S; Pistolesi V; Tritapepe L; Zeppilli L; Polistena F; Strampelli E; Pierucci A
    Crit Care; 2012 Jun; 16(3):R111. PubMed ID: 22738289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two regional citrate anticoagulation modalities for continuous renal replacement therapy by a prospective analysis of safety, workload, effectiveness, and cost.
    Cassina T; Villa M; Soldani-Agnello A; Zini P
    Minerva Anestesiol; 2021 Dec; 87(12):1309-1319. PubMed ID: 34527405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional Citrate Anticoagulation for Continuous Kidney Replacement Therapy With Calcium-Containing Solutions: A Cohort Study.
    Rhee H; Berenger B; Mehta RL; Macedo E
    Am J Kidney Dis; 2021 Oct; 78(4):550-559.e1. PubMed ID: 33798636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy: An Observational Study.
    Bianchi NA; Altarelli M; Eckert P; Schneider AG
    Blood Purif; 2020; 49(5):567-575. PubMed ID: 32126564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional citrate anticoagulation versus low molecular weight heparin for CRRT in hyperlactatemia patients: A retrospective case-control study.
    Li L; Bai M; Zhang W; Zhao L; Yu Y; Sun S
    Int J Artif Organs; 2022 Apr; 45(4):343-350. PubMed ID: 33784842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration.
    Tiranathanagul K; Jearnsujitwimol O; Susantitaphong P; Kijkriengkraikul N; Leelahavanichkul A; Srisawat N; Praditpornsilpa K; Eiam-Ong S
    Ther Apher Dial; 2011 Dec; 15(6):556-64. PubMed ID: 22107692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding.
    Palsson R; Niles JL
    Kidney Int; 1999 May; 55(5):1991-7. PubMed ID: 10231464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study.
    Slowinski T; Morgera S; Joannidis M; Henneberg T; Stocker R; Helset E; Andersson K; Wehner M; Kozik-Jaromin J; Brett S; Hasslacher J; Stover JF; Peters H; Neumayer HH; Kindgen-Milles D
    Crit Care; 2015 Sep; 19():349. PubMed ID: 26415638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid-base status and phosphate supplementation needs.
    Morabito S; Pistolesi V; Tritapepe L; Vitaliano E; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
    BMC Nephrol; 2013 Oct; 14():232. PubMed ID: 24156306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous venovenous hemofiltration with or without predilution regional citrate anticoagulation: a prospective study.
    Nurmohamed SA; Vervloet MG; Girbes AR; Ter Wee PM; Groeneveld AB
    Blood Purif; 2007; 25(4):316-23. PubMed ID: 17700015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and efficacy of modified fixed citrate concentration protocol using only commercial preparations in critically ill patients: a prospective cohort study with a historical control group.
    Shi Y; Qin HY; Peng JM; Hu XY; Du B
    BMC Anesthesiol; 2021 Mar; 21(1):96. PubMed ID: 33784963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium supplementation in CVVH using regional citrate anticoagulation.
    Zheng Y; Xu Z; Fan Q; Zhu Q; Ma S; Lu J; Zhuang F; Hao G; Lu W; Ding F
    Hemodial Int; 2019 Jan; 23(1):33-41. PubMed ID: 30716204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
    Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citrate and low-dose heparin combined anticoagulation in pediatric continuous renal replacement therapy.
    Zhu D; He J; Xiao Z; Zhou X; Zhang X
    Sci Rep; 2024 Jun; 14(1):13504. PubMed ID: 38866989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.